Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hauser, S. L.
Right arrow Articles by Henderson, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hauser, S. L.
Right arrow Articles by Henderson, C. E.
NEUROLOGY 1986;36:1614
© 1986 American Academy of Neurology

Immunoblot analysis of circulating antibodies against muscle proteins in amyotrophic lateral sclerosis and other neurologic diseases

Stephen L. Hauser, Pierre-André Cazenave, Olivier Lyon-Caen, Takahisa Taguchi, Monique Huchet, Henriette Nuret, Jean-Pierre Changeux and Christopher E. Henderson

Unités d'Immunochimie Analytique and Neurobiolugie Moléculaire, Institut Pasteur, and the Hôpital Salpétrière, Paris, France.

Serum from patients with amyotrophic lateral sclerosis (ALS) was tested by immunoblotting for reactivity against three muscle-derived preparations: denervated chick leg muscle extracts, media conditioned by denervated rat hemidiaphragms, and a human muscle extract. For each preparation, multiple bands were present using serum from all patients and controls, and no band was unique to ALS. Against rat muscle-conditioned medium, bands in the 56,000 (56K) molecular weight range were present to an equal degree in ALS and in controls; in addition, different bands near 56K were recognized by serum from different ALS patients. These results fail to confirm a recent report suggesting that anti-56K reactivity is characteristic of ALS.

Address correspondence and reprint requests to Dr. Mauser, Department of Neurology, Massachusetts General Hospital, Fruit Street, Boston, MA 02114.

Dr. Mauser is a fellow of the Moseley Foundation of Harvard University.

Accepted for publication March 26, 1986.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.